| 1 | Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. (Crane GM, Geyer JT, Thakral B, Wang SA, Wool GD, Li KD, Davis AR, Boiocchi L, Bosler D, Bueso-Ramos CE, Arber DA, George TI, Bagg A, Hasserjian RP, Orazi A, Hsi ED, Rogers HJ) Am J Clin Pathol 2024 Sep 03;162(3):233-242 6 Citations |
| 1 | Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis. (Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik M, Abid MB, Aljurf M, Arai Y, Bacher U, Badar T, Badawy SM, Ballen K, Battiwalla M, Beitinjaneh A, Bejanyan N, Bhatt VR, Brown VI, Martino R, Cahn JY, Castillo P, Cerny J, Chhabra S, Copelan E, Daly A, Dholaria B, Diaz Perez MA, Freytes CO, Grunwald MR, Hashmi S, Hildebrandt GC, Jamy O, Joseph J, Kanakry CG, Khera N, Krem MM, Kuwatsuka Y, Lazarus HM, Lekakis LJ, Liu H, Modi D, Munshi PN, Mussetti A, Palmisiano N, Patel SS, Rizzieri DA, Seo S, Shah MV, Sharma A, Sohl M, Solomon SR, Ulrickson M, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wang T, Wirk B, Zeidan A, Litzow M, Kebriaei P, Hourigan CS, Weisdorf DJ, Saber W, Kharfan-Dabaja MA) Blood Adv 2023 Nov 28;7(22):7007-7016 18 Citations |
| 3 | Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies. (Gorak EJ, Otterstatter M, Al Baghdadi T, Gillis N, Foran JM, Liu JJ, Bejar R, Gore SD, Kroft SH, Harrington A, Saber W, Starczynowski D, Rollison DE, Zhang L, Moscinski L, Wilson S, Thompson J, Borchert C, Sherman S, Hebert D, Walker ME, Padron E, DeZern AE, Sekeres MA) Blood Adv 2023 Oct 24;7(20):6120-6129 10 Citations |
| 3 | Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions. (DeZern AE, Goll JB, Lindsley RC, Bejar R, Wilson SH, Hebert D, Deeg J, Zhang L, Gore S, Al Baghdadi T, Maciejewski J, Liu J, Padron E, Komrojki R, Saber W, Abel G, Kroft SH, Harrington A, Grimes T, Reed H, Fulton RS, DiFronzo NL, Gillis N, Sekeres MA, Walter MJ) Blood Adv 2023 Jul 25;7(14):3749-3759 8 Citations |
| 7 | A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. (Kleman A, Singavi A, Pommert L, Mathison AJ, Hari P, Dhakal B, Mohan M, Janz S, Knight JM, Shah MV, Schinke C, Burns R, Steinhardt GF, Rao S, Carlson K) Blood Adv 2023 Sep 26;7(18):5549-5553 1 Citation |
| 1 | Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms. (Chovanec J, Tunc I, Hughes J, Halstead J, Mateja A, Liu Y, O'Connell MP, Kim J, Park YH, Wang Q, Le Q, Pirooznia M, Trivedi NN, Bai Y, Yin Y, Hsu AP, McElwee J, Lassiter S, Nelson C, Bandoh J, DiMaggio T, Šelb J, Rijavec M, Carter MC, Komarow HD, Sabato V, Steinberg J, Hafer KM, Feuille E, Hourigan CS, Lack J, Khoury P, Maric I, Zanotti R, Bonadonna P, Schwartz LB, Milner JD, Glover SC, Ebo DG, Korošec P, Caughey GH, Brittain EH, Busby B, Metcalfe DD, Lyons JJ) Blood Adv 2023 May 09;7(9):1796-1810 47 Citations |
| 2 | Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis. (Brown DW, Zhou W, Wang Y, Jones K, Luo W, Dagnall C, Teshome K, Klein A, Zhang T, Lin SH, Lee OW, Khan S, Vo JB, Hutchinson A, Liu J, Wang J, Zhu B, Hicks B, Martin AS, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Freedman ND, Yeager M, Chanock SJ, Savage SA, Saber W, Gadalla SM, Machiela MJ) Nat Commun 2022 Sep 08;13(1):5284 11 Citations |
| 1 | Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report. (Turcotte LM, Whitton JA, Leisenring WM, Howell RM, Neglia JP, Phelan R, Oeffinger KC, Ness KK, Woods WG, Kolb EA, Robison LL, Armstrong GT, Chow EJ) Blood 2023 Jan 05;141(1):90-101 7 Citations |
| 1 | Management of Myeloproliferative Neoplasms in the Molecular Era: From Research to Practice. (Pettit K, Rezazadeh A, Atallah EL, Radich J) Am Soc Clin Oncol Educ Book 2022 Apr;42:1-19 |
| 1 | Increased B4GALT1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in MPNs. (Di Buduo CA, Giannini S, Abbonante V, Rosti V, Hoffmeister KM, Balduini A) Blood 2021 Apr 15;137(15):2085-2089 13 Citations |
| 1 | Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5. (Guru SA, Sumi MP, Mir R, Waza AA, Bhat MA, Zuberi M, Lali P, Saxena A) Hum Cell 2020 Oct;33(4):1099-1111 14 Citations |
| 2 | Stem cell damage after chemotherapy- can we do better? (Tang J, Zhu N, Rao S, Carlson KS) Best Pract Res Clin Haematol 2019 Mar;32(1):31-39 7 Citations |
| 2 | Myeloid malignancies after treatment for solid tumours. (Guru Murthy GS, Abedin S) Best Pract Res Clin Haematol 2019 Mar;32(1):40-46 12 Citations |
| 1 | Preface. (Michaelis LC) Best Pract Res Clin Haematol 2019 Mar;32(1):1-2 |
| 5 | Incidence and survival of therapy related myeloid neoplasm in United States. (Guru Murthy GS, Hamadani M, Dhakal B, Hari P, Atallah E) Leuk Res 2018 Aug;71:95-99 34 Citations |
| 1 | Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. (Sachs Z, Been RA, DeCoursin KJ, Nguyen HT, Mohd Hassan NA, Noble-Orcutt KE, Eckfeldt CE, Pomeroy EJ, Diaz-Flores E, Geurts JL, Diers MD, Hasz DE, Morgan KJ, MacMillan ML, Shannon KM, Largaespada DA, Wiesner SM) Haematologica 2016 Oct;101(10):1190-1199 16 Citations |
| 2 | Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research. (Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Müller CR, Fernandez-Viña MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ) Haematologica 2016 Oct;101(10):1267-1274 19 Citations |
| 2 | Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms. (Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H) Am J Clin Pathol 2016 Apr;145(4):538-51 27 Citations |
| 1 | Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it? (Barosi G, Zhang MJ, Gale RP) Leukemia 2014 Nov;28(11):2267-70 23 Citations |
| 1 | Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. (Yan M, Geyer H, Mesa R, Atallah E, Callum J, Bartoszko J, Yee K, Maganti M, Wong F, Gupta V) Clin Lymphoma Myeloma Leuk 2015 Jan;15(1):e1-5 27 Citations |
| 1 | Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. (Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C) J Clin Oncol 2014 Aug 01;32(22):2365-72 79 Citations |
| 1 | Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP. (Chaudhary LN, Bailey NG, Vos JA, Stotler CJ) W V Med J 2013;109(2):6-9 3 Citations |
| 1 | Myeloproliferative neoplasms. (Kim J, Haddad RY, Atallah E) Dis Mon 2012 Apr;58(4):177-94 9 Citations |
| 2 | The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders. (Harrington A, Olteanu H, Kroft S) Am J Clin Pathol 2010 Nov;134(5):749-61 27 Citations |
| 1 | Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. (Oravecz-Wilson KI, Philips ST, Yilmaz OH, Ames HM, Li L, Crawford BD, Gauvin AM, Lucas PC, Sitwala K, Downing JR, Morrison SJ, Ross TS) Cancer Cell 2009 Aug 04;16(2):137-48 63 Citations |
| 1 | Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. (Atallah E, Verstovsek S) Expert Rev Anticancer Ther 2009 May;9(5):663-70 29 Citations |
| 2 | Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. (Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E) Leuk Res 2009 Aug;33(8):1144-6 34 Citations |
| 1 | Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. (Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S) Leukemia 2008 Jun;22(6):1295-8 29 Citations |
| 1 | Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. (Kim A, Morgan K, Hasz DE, Wiesner SM, Lauchle JO, Geurts JL, Diers MD, Le DT, Kogan SC, Parada LF, Shannon K, Largaespada DA) Blood 2007 Feb 15;109(4):1687-91 23 Citations |
| 1 | The second international congress on myeloproliferative and myelodysplastic syndromes. (Silver RT, Bennett JM, Deininger M, Feldman E, Rafii S, Silverstein RL, Solberg LA, Spivak JL) Leuk Res 2004 Sep;28(9):979-85 6 Citations |
| 1 | Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. (Karandikar NJ, Aquino DB, McKenna RW, Kroft SH) Am J Clin Pathol 2001 Aug;116(2):204-10 94 Citations |
| 1 | Prenatal diagnosis of transient myeloproliferative disorder via percutaneous umbilical blood sampling. Report of two cases in fetuses affected by Down's syndrome. (Foucar K, Friedman K, Llewellyn A, McConnell T, Aisenbrey G, Argubright K, Ballinger L) Am J Clin Pathol 1992 Apr;97(4):584-90 21 Citations |
| 1 | Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis. (Talpaz M, Kurzrock R, Kantarjian H, O'Brien S, Gutterman JU) Am J Med 1989 May;86(5):554-8 36 Citations |
| 1 | Preleukemic syndromes and other syndromes predisposing to leukemia. (Schwartz CL, Cohen HJ) Pediatr Clin North Am 1988 Aug;35(4):853-71 10 Citations |
